|
KMID : 0360220210620030322
|
|
Journal of the Korean Ophthalmological Society
2021 Volume.62 No. 3 p.322 ~ p.328
|
|
|
The Effect of an Intravitreal Dexamethasone Implant for Refractory Posterior Scleritis
|
|
Choi Seung-Kwon
Choi Youn-A
Kim So-Hee
Lee Jae-Jung
Byon Ik-Soo
Lee Ji-Eun
Park Sung-Who
|
|
|
Abstract
|
|
|
Purpose: To report the effect of an intravitreal dexamethasone implant on refractory posterior scleritis.
Methods: The medical records of patients treated with an intravitreal dexamethasone implant for non-infectious refractory posterior scleritis were retrospectively reviewed, including age, sex, duration of follow-up, and presence of associated systemic diseases. The duration until relapse, changes in visual acuity, number of implants, and side effects associated with the implant were also analyzed.
Results: Seven eyes from five patients were included. The mean age was 73.2 ± 12.5 years (59-92 years). Although all patients had been treated with high-dose systemic steroid, and immunosuppressants were added, the posterior scleritis was poorly controlled. The duration from the diagnosis to the first dexamethasone implant was a mean of 8.2 months (3-27 months). The scleritis was well controlled in all eyes until at least 2 months (2-5 months) after inserting the implant. An average of 2.1 (total of 15 times in the seven eyes) implants were inserted. No complications related to the implant were observed other than a temporary increase in intraocular pressure in one eye.
Conclusions: Intravitreal dexamethasone implants were an effective treatment option for refractory posterior scleritis.
|
|
|
KEYWORD
|
|
|
Choroid fold, Dexamethasone, Posterior scleritis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|